Candriam SCA’s iKang Healthcare Group, Inc. KANG Stock Holding History

Candriam SCA’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,000	Closed	-$286K	–	663
2015 Q4	$286K	Sell	14,000 -231,000	-94%	-$3.99M	0.01%	517
2015 Q3	$3.63M	Sell	245,000 -78,000	-24%	-$1.26M	0.09%	248
2015 Q2	$6.25M	Sell	323,000 -166,000	-34%	-$3.05M	0.13%	201
2015 Q1	$7.93M	Buy	489,000 +46,000	+10%	+$767K	0.16%	177
2014 Q4	$6.66M	Buy	+443,000	New	+$7.88M	0.14%	192

Other funds holding KANG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ASI

All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Candriam SCA's KANG Position: Q1 2016 in Review

Candriam SCA sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2016, closing a stake of 14,000 shares — an estimated $286K sold.

Candriam SCA first reported a position in KANG in Q4 2014 and held it in 5 quarters. The position peaked at $7.93M in Q1 2015. 73 funds tracked by Wall St. Rank hold KANG as of Q1 2016.

Candriam SCA reported no remaining iKang Healthcare Group, Inc. position as of Q1 2016 after selling out during the quarter.
Candriam SCA sold 14,000 iKang Healthcare Group, Inc. shares in Q1 2016, an estimated $286K.
Candriam SCA first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 5 quarters.
Candriam SCA's iKang Healthcare Group, Inc. position peaked at $7.93M in Q1 2015.
73 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2016.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.